Price
No data yet.
Social Signal Score
Analyst Ratings
9 analystsRevenue
$1.25T+197.57%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Kentaro Okuda
- Sector
- Financial Services
- Industry
- Financial - Capital Markets
- Employees
- 28,677
- Beta
- 0.60
- Country
- JP
- Piotroski score
- 4 / 9 (Middling)
- Altman Z-score
- 0.12
Financials
Revenue
$1.25T+197.6%Net Income
$103.73B+47.5%EBITDA
$148.00B+30.5%Free Cash Flow
—EPS (diluted)
$34.61+78.0%Shares Outstanding (diluted)
3.00B-17.1%Operating Expenses
$224.00BCash & Debt
$34.65TReturn of Capital
$0.00Revenue by Segment (annual)
$340.90BDividend per Share
$0.17Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2026 | $4.76T | $362.13B | $123.08 |
| 2025 | $4.51T | $340.74B | $115.30 |
| 2024 | $3.97T | $165.86B | $54.97 |
| 2023 | $2.30T | $92.79B | $30.86 |
| 2022 | $1.37T | $143.00B | $46.68 |
| 2021 | $1.41T | $153.12B | $50.11 |
| 2020 | $1.74T | $217.00B | $67.76 |
| 2019 | $1.73T | $-100.44B | $-29.90 |
| 2018 | $1.77T | $219.34B | $63.13 |
| 2017 | $1.59T | $239.62B | $67.29 |
| 2016 | $1.57T | $131.55B | $36.53 |
| 2015 | $1.73T | $224.78B | $61.66 |
| 2014 | $1.72T | $213.59B | $57.57 |
| 2013 | $1.99T | $107.23B | $29.04 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from NMR's reported EPS growth of 11.7% a year over 13 years.
- EPS in 5 years
- $214.02
- Implied price
- $2,140
- Return from $8.51
- 202.1% a year
To earn 15.0% a year on these assumptions you'd need to buy at $1,064 — today's price is already 99.2% below that.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 6 | 8 | 10 | 12 | 14 |
|---|---|---|---|---|---|
| 1.7% | 148.3% | 163.0% | 175.0% | 185.2% | 194.2% |
| 6.7% | 160.5% | 176.0% | 188.5% | 199.3% | 208.6% |
| 11.7% | 172.7% | 188.9% | 202.1% | 213.3% | 223.1% |
| 16.7% | 184.9% | 201.8% | 215.6% | 227.3% | 237.6% |
| 21.7% | 197.1% | 214.7% | 229.1% | 241.3% | 252.0% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
45-18.18%Social Signal Score
Mentions (13)
- Newsbusinesswire.com·10d ago·Neutral
Nomura and CC Capital-Backed Aventus Enter Joint Venture to Launch Misura, a Securitized Products and Private Credit Investment Management Platform NEW YORK--(BUSINESS WIRE)--Nomura, a global financial services group, and Aventus (TSXV: AVTS), an integrated insurance and alternative asset management company backed by CC Capital, today announced the launch of a joint venture designed to offer investors access to differentiated opportunities primarily across securitized products and private credit
View source ↗ - Newszacks.com·20d ago·Neutral
NMR or TW: Which Is the Better Value Stock Right Now? Investors looking for stocks in the Financial - Investment Bank sector might want to consider either Nomura Holdings (NMR) or Tradeweb Markets (TW). But which of these two stocks offers value investors a better bang for their buck right now?
View source ↗ - Newsseekingalpha.com·25d ago·Positive
Nomura Holdings, Inc. (NMR) Q2 2027 Earnings Call Transcript Nomura Holdings, Inc. (NMR) Q2 2027 Earnings Call Transcript
View source ↗ - Newszacks.com·30d ago·Neutral
Nomura to Report Q2 Earnings: What's in Store for the Stock? NMR's Q2 earnings are expected to decline 9.1% y/y despite healthy equity trading, wealth management inflows and higher investment management fees.
View source ↗ - Newszacks.com·38d ago·Neutral
NMR vs. TW: Which Stock Is the Better Value Option? Investors interested in Financial - Investment Bank stocks are likely familiar with Nomura Holdings (NMR) and Tradeweb Markets (TW). But which of these two stocks is more attractive to value investors?
View source ↗ - Newszacks.com·38d ago·Positive
Down 11.4% in 4 Weeks, Here's Why You Should You Buy the Dip in Nomura (NMR) The heavy selling pressure might have exhausted for Nomura (NMR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
View source ↗ - Newsaccessnewswire.com·38d ago·Negative
Valion Bio's Next-Generation NMR Partnership with LarmorBio Delivers Initial Feasibility Milestone Velocity Bioworks successfully completes initial evaluation of LarmorBio's BioScan-NMR™ platform, generating data supporting the continued development of continuous, real-time, non-invasive bioprocess monitoring of cell size, density, viability, and phenotype within bioreactors Milestone achieved less than six months after Valion Bio secured exclusive rights to LarmorBio's next-generation NMR techn…
View source ↗ - Newszacks.com·51d ago·Negative
Nomura (NMR) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? Nomura (NMR) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
View source ↗ - Newszacks.com·54d ago·Positive
NMR or TW: Which Is the Better Value Stock Right Now? Investors interested in stocks from the Financial - Investment Bank sector have probably already heard of Nomura Holdings (NMR) and Tradeweb Markets (TW). But which of these two companies is the best option for those looking for undervalued stocks?
View source ↗ - Newsyoutube.com·60d ago·Neutral
Japan's fiscal gamble has JGB market ‘flashing warning signs', says Nomura Nomura's Rob Subbaraman says Japan's bond market is “flashing warning signs” as Prime Minister Sanae Takaichi pursues fiscal stimulus aimed at lifting nominal growth. He says rising borrowing costs could threaten that strategy, while largely cost-driven inflation complicates the Bank of Japan's tightening path.
View source ↗ - Newszacks.com·81d ago·Negative
Nomura (NMR) is on the Move, Here's Why the Trend Could be Sustainable Nomura (NMR) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
View source ↗ - Newsseekingalpha.com·83d ago·Neutral
Nomura Value Fund Q2 2026 Portfolio Activity After outperforming its benchmark in 1Q2026, the Nomura Value Fund Institutional Class shares lost considerable ground to the Russell 1000® Value Index in 2Q2026. Positive stock selection results in the communication services and materials sectors were leading contributors for the quarter. During the quarter, we made two full-position sales while initiating six new positions in the Strategy.
View source ↗ - Newszacks.com·97d ago·Positive
Recent Price Trend in Nomura (NMR) is Your Friend, Here's Why Nomura (NMR) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
View source ↗
Earnings
Fri, Jan 29(in 2 months)
Consensus estimate $0.22 per share
Typical surprise -5.1% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Oct 28$0.22 vs $0.20beat
- Wed, Jul 29$0.30 vs $0.23beat
- Fri, Apr 24$0.16 vs $0.21miss
- Fri, Jan 30$0.18 vs $0.24miss
- Fri, Nov 7$0.22 vs $0.17beat
- Tue, Jul 29$0.24 vs $0.25miss
Estimates and results for NMR via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by NMR officers and directors.
No open-market trades in the recent filings. All 100 recent Form 4 entries were share awards, option exercises or tax withholding — pay, not decisions to buy or sell.
100 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Alan Armstrongsenate · disclosed Jul 21, 2026 (113d later)Buy$1,001 - $15,000
- Daniel Goldmanhouse · NY10 · disclosed Aug 13, 2023 (34d later)Sell$15,001 - $50,000
- Greg Gianfortehouse · MT00 · disclosed Jan 23, 2019 (33d later)Buy$1,001 - $15,000
- Greg Gianfortehouse · MT00 · disclosed Dec 11, 2018 (22d later)Sell$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
